That’s according to a clinical trial conducted in 11 countries — the first of its kind to show that one of the wave of ...

A new study reveals that among privately insured patients with obesity, weight loss drug use has more than doubled and ...

2024 — A new study has examined a large sample of privately insured patients with obesity and found that use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) as anti-obesity medications ...

Nutrition Changes: There are several nutrition strategies that can help improve insulin resistance. For healthy blood sugar ...

Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...

There’s an innate tension between school safety and students’ civil rights. The 74’s Mark Keierleber keeps you up to date on ...

SAN ANTONIO, Tx - Cancer patients need a lot of drugs—immunotherapies, chemotherapies, and anti-infectives. But new research at ObesityWeek® on Nov. 3, 2024, shows clinicians may not have all the ...

The updated AAP clinical guidelines on obesity treatment recommend offering the full spectrum of care upon initial obesity ...

CRB-913 brain levels are 15-fold lower than monlunabant in lean miceDose-response demonstrated for a range of 5 to 80 mg/kg/day achieving up to ...

We include anti-inflammatory ingredients such as salmon ... the risk of developing type 2 diabetes and the progression of obesity-linked insulin resistance. Reducing chronic inflammation can ...